Physician profile
Vera A Meier-Bennett
NPI 1326085572
$798.22
in general payments reported to CMS, 2019-2025
20 companies · $145 in 2025
The $145 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.31 · 2020: $70.53 · 2021: $164 · 2022: $157 · 2023: $53.72 · 2024: $140 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $150.10 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $95.81 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $61.83 | 2022-2025 | Bexsero, Rotarix |
| Merck Sharp & Dohme LLC | $59.97 | 2020-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Takeda Pharmaceuticals U.S.A., INC. | $59.42 | 2020-2022 | |
| Cranial Technologies, INC | $59.38 | 2024-2025 | Doc Band |
| Corium, LLC | $43.08 | 2022-2023 | Azstarys |
| Phadia US INC. | $29.50 | 2020-2021 | |
| Roche Diagnostics Corporation | $26.43 | 2019 | |
| Metacel Pharmaceuticals LLC | $24.76 | 2024 | Ozobax |
| Hologic Sales and Service, LLC | $23.74 | 2025 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $22.17 | 2024 | |
| Ironwood Pharmaceuticals, INC | $19.59 | 2024 | |
| Novo Nordisk INC | $19.03 | 2024 | Wegovy |
| Uswm, LLC | $19.00 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $18.76 | 2022 | |
| Kyowa Kirin, INC. | $18.69 | 2025 | |
| Sanofi Pasteur INC. | $18.23 | 2023 | |
| Sarepta Therapeutics, INC. | $17.61 | 2019 | |
| Shire North American Group INC | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vera Meier-Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.